作者
Judith A Schwartzbaum, James L Fisher, Kenneth D Aldape, Margaret Wrensch
发表日期
2006/9
来源
Nature clinical practice Neurology
卷号
2
期号
9
页码范围
494-503
出版商
Nature Publishing Group UK
简介
Gliomas account for almost 80% of primary malignant brain tumors, and they result in more years of life lost than do any other tumors. Glioblastoma, the most common type of glioma, is associated with very poor survival, so glioma epidemiology has focused on identifying factors that can be modified to prevent this disease. Only two relatively rare factors have so far been conclusively shown to affect glioma risk—exposure to high doses of ionizing radiation, and inherited mutations of highly penetrant genes associated with rare syndromes. In addition, preliminary evidence points to a lower glioma risk among people with allergic conditions and high levels of serum IgE. Recent research has focused on identifying germline polymorphisms associated with risk of glioma, and using molecular markers to classify glial tumors into more-homogenous groups. Because gene products probably interact with environmental factors …
引用总数
2007200820092010201120122013201420152016201720182019202020212022202320241326313235526383951051199310189109835730
学术搜索中的文章
JA Schwartzbaum, JL Fisher, KD Aldape, M Wrensch - Nature clinical practice Neurology, 2006